Personalized Branched Amino Acid Surfactant-Based Healthcare Products and Systems

Publication ID: 24-11857515_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Personalized Branched Amino Acid Surfactant-Based Healthcare Products and Systems,” Published Technical Disclosure No. 24-11857515_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857515_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,515.

Summary of the Inventive Concept

A next-generation system for generating customized healthcare products utilizing branched amino acid surfactants, integrating user-specific preferences, predictive analytics, and machine learning-based molecular modeling to optimize surface-active properties and create targeted formulations.

Background and Problem Solved

The original patent disclosed branched amino acid surfactants for use in healthcare products, but it lacked the ability to tailor these surfactants to individual users' needs and preferences. The present inventive concept addresses this limitation by introducing a system that combines user-specific data, advanced analytics, and molecular modeling to create personalized healthcare products with optimized surface-active properties.

Detailed Description of the Inventive Concept

The inventive concept comprises a database of user-specific surfactant preferences, a predictive analytics module, and a formulation generator that utilizes branched amino acid surfactants to create customized products. Additionally, the system incorporates machine learning-based molecular modeling and simulation to optimize the surface-active properties of the surfactants. This enables the creation of targeted formulations that address specific skin concerns and health needs. The system can be integrated with wearable devices, virtual reality platforms, and modular product platforms to provide users with real-time customization and monitoring capabilities.

Novelty and Inventive Step

The new claims introduce a paradigm shift in the field of branched amino acid surfactants by integrating user-specific data, predictive analytics, and machine learning-based molecular modeling to create personalized healthcare products. This approach is novel and non-obvious compared to the original patent, which focused solely on the surfactants' composition and properties.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different types of user data, such as genetic information or medical history, to further personalize the healthcare products. Additionally, the system could be adapted for use in various industries, such as cosmetics or pharmaceuticals, or integrated with emerging technologies like artificial intelligence or the Internet of Things.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the healthcare industry, particularly in the areas of personalized medicine and customized skincare. The system's ability to provide targeted formulations and real-time customization capabilities addresses a growing demand for personalized healthcare products, making it an attractive solution for companies seeking to differentiate themselves in the market.

CPC Classifications

SectionClassGroup
A A61 A61K47/183
A A61 A61K9/0019
A A61 A61K9/08
A A61 A61K9/107
A A61 A61K31/5377
A A61 A61K31/55
A A61 A61K47/186
A A61 A61K47/20

Field of Art

Healthcare product formulation and surfactant chemistry, specifically focusing on amino acid-based surface-active compounds with applications in pharmaceutical, cosmetic, and medical delivery systems. Requires advanced knowledge of organic chemistry, molecular modeling, and formulation science

Person of Ordinary Skill (PHOSITA) Profile

A professional with a PhD or equivalent industrial experience in chemical engineering, pharmaceutical sciences, or materials chemistry, with expertise in surfactant design, molecular interactions, and product development methodologies

Obviousness Rationale

A PHOSITA would recognize that integrating machine learning, predictive analytics, and personalization technologies with existing surfactant formulation techniques represents a natural evolutionary progression in product development. The core surfactant chemistry remains fundamentally consistent with the source patent, while the proposed system merely applies standard computational and data-driven design methodologies to enhance customization and optimization. These technological extensions represent predictable applications of known techniques to an established scientific domain.

Obvious Combinations & Variations

Source Patent Element
Branched amino acid surfactants with surface-active properties for healthcare products
PTD Variation
Machine learning-based molecular modeling to optimize surfactant properties
Obviousness Reasoning
Computational optimization of molecular structures is a standard technique in materials science, representing a predictable application of computational methods to existing chemical formulations
Source Patent Element
Healthcare formulations using surfactant compounds
PTD Variation
User-specific data-driven customization of surfactant-based products
Obviousness Reasoning
Personalization of healthcare products through data analysis is a known trend, and applying this approach to surfactant formulations represents an obvious design choice for product differentiation
Source Patent Element
Surfactant compositions for healthcare applications
PTD Variation
Modular product platforms with interchangeable surfactant cartridges
Obviousness Reasoning
Modular design approaches are common in pharmaceutical and consumer product development, representing a straightforward extension of existing product design principles
Source Patent Element
Surface-active amino acid derivatives for healthcare use
PTD Variation
Integration with wearable devices for real-time product dispensing
Obviousness Reasoning
Combining medical formulations with wearable technology is a predictable technological convergence in healthcare innovation
Source Patent Element
Surfactant formulations with variable molecular configurations
PTD Variation
Virtual reality simulation of surfactant-tissue interactions
Obviousness Reasoning
Advanced computational modeling techniques are standard in materials and pharmaceutical research, representing an expected technological progression
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857515 and the disclosed technological variations, a person having ordinary skill in the art would find the proposed personalized surfactant systems and computational optimization methodologies to be obvious extensions of existing chemical formulation and product development techniques. The combination of known surfactant chemistry with emerging computational and personalization technologies represents a predictable and non-inventive approach to healthcare product innovation.

Original Patent Information

Patent NumberUS 11,857,515
TitleBranched amino acid surfactants for use in healthcare products
Assignee(s)AdvanSix Resins & Chemicals LLC